Convergence Investment Partners LLC Purchases 784 Shares of Genpact Limited $G

Convergence Investment Partners LLC raised its position in shares of Genpact Limited (NYSE:GFree Report) by 4.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,808 shares of the business services provider’s stock after acquiring an additional 784 shares during the quarter. Convergence Investment Partners LLC’s holdings in Genpact were worth $740,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the company. Cornerstone Planning Group LLC bought a new position in shares of Genpact during the 1st quarter worth about $27,000. Richardson Financial Services Inc. bought a new position in Genpact in the first quarter worth approximately $35,000. Steph & Co. bought a new position in Genpact in the second quarter worth approximately $37,000. SVB Wealth LLC bought a new position in Genpact in the first quarter worth approximately $41,000. Finally, Kestra Investment Management LLC bought a new position in Genpact in the first quarter worth approximately $56,000. Institutional investors own 96.03% of the company’s stock.

Genpact Trading Up 0.1%

NYSE:G opened at $39.52 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53. The firm has a market cap of $6.89 billion, a price-to-earnings ratio of 13.13, a price-to-earnings-growth ratio of 1.36 and a beta of 0.89. Genpact Limited has a 52 week low of $37.82 and a 52 week high of $56.76. The firm has a 50-day moving average price of $42.20 and a two-hundred day moving average price of $43.85.

Genpact (NYSE:GGet Free Report) last posted its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 EPS for the quarter, beating the consensus estimate of $0.85 by $0.03. The firm had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.23 billion. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter last year, the business posted $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, equities analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, December 9th will be paid a $0.17 dividend. The ex-dividend date is Tuesday, December 9th. This represents a $0.68 annualized dividend and a yield of 1.7%. Genpact’s dividend payout ratio (DPR) is 22.59%.

Insider Activity

In other Genpact news, SVP Piyush Mehta sold 76,902 shares of the stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $42.58, for a total value of $3,274,487.16. Following the completion of the sale, the senior vice president owned 134,880 shares in the company, valued at approximately $5,743,190.40. This trade represents a 36.31% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the sale, the chief executive officer owned 295,246 shares of the company’s stock, valued at approximately $12,801,866.56. This trade represents a 15.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 3.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Needham & Company LLC increased their price target on Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a report on Friday, August 8th. JPMorgan Chase & Co. cut their price target on Genpact from $55.00 to $50.00 and set a “neutral” rating on the stock in a report on Wednesday, August 20th. Weiss Ratings reiterated a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Genpact in a research report on Thursday, July 17th. They issued a “hold” rating and a $47.00 price target on the stock. Finally, Citigroup raised shares of Genpact to a “hold” rating in a research report on Thursday, October 23rd. Three investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Genpact presently has an average rating of “Hold” and an average target price of $51.13.

View Our Latest Report on Genpact

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.